This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

More Of The Same Medicine From The Fed

If you are ailing, and you take a medicine that doesn't work, do you up the dosage or try something else?

For Ben Bernanke and the Federal Reserve, the answer seems clear: More is always the way to go.

An open-ended commitment

In the meeting of the Federal Open Market Committee that concluded September 13, the Fed decided on another round of quantitative easing -- QE3, for those of you keeping score.

In essence, the Fed is lengthening its commitment to low interest rates. It is now saying that it sees a likelihood of keeping the Fed funds rate at "exceptionally low levels" at least through the middle of 2015. Also, in announcing that it will make additional purchases of mortgage-backed securities, the Fed did not use a timetable or total amount to describe the extent of this new program -- it merely made an open-ended commitment to purchase additional mortgage-backed securities at a pace of $40 billion per month.

Over the past year, the Fed has put a great deal of emphasis on how it communicates its policies, and it is significant that the Fed is now signalling that low interest rates are here to stay for the foreseeable future. Having lowered interest rates about as far as it can, the Fed is now hoping to get extra psychological mileage out of the message that people can expect these low rates to continue for a long time.

Three problems with the policy

The stock market got a quick fix out of the announcement, but it is important not to confuse the market's interests with the broader well-being of the economy. There is some overlap, of course, but stock valuation formulas yield higher prices when interest rates are low. Given how short-sighted most stock investors are, the promise of more low interest rates is enough to spark a rally, regardless of whether it ultimately helps the economy.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASDAQ 4,683.9190 -49.5780 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs